117th Congress · HOUSE BILLINCORPORATED

H.R. 2815BIOSIM Act

To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.

Health
Introduced Apr 22, 2021
Last action Apr 23, 2021
Pipeline · Bill → Law
Step 1
Introduced
Apr 22, 2021
Step 2
Referred
Apr 23, 2021
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Similar Bills · 1 matches
BillText overlapStatus
H.R. 5376Inflation Reduction Act of 2022
0%
ENACTED
Timeline · 6 actions
Apr 23, 2021
Referred to the Subcommittee on Health.
Apr 22, 2021
Introduced in House
Apr 22, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 22, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 22, 2021
Referred to the Subcommittee on Health.
Apr 22, 2021
Referred to the Subcommittee on Social Security.